Oncolytics Biotech Inc (ONCY) stock
ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38+0.04 (+12.53%)
Close on Nov 17, 2026Market cap $48.77MP/E –Yield –
Oncolytics Biotech operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2018 it was -3153.7%, against -252.4% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | -3153.7% | −2901.2 |
| FY2017 | Dec 31, 2017 | -252.4% | – |
See a number that looks wrong?